These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19135531)

  • 1. Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats.
    Gao J; Ding X; Chu C; Lu L; Zhang Y; Chen Y; Fan W; Li G; Gao S
    Eur J Pharm Sci; 2009 Mar; 36(4-5):572-9. PubMed ID: 19135531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a new inhalable thymopentin formulation.
    Wang L; Zhang Y; Tang X
    Int J Pharm; 2009 Jun; 375(1-2):1-7. PubMed ID: 19443146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of formulation components on the aerosolisation properties of spray-dried powders.
    Rabbani NR; Seville PC
    J Control Release; 2005 Dec; 110(1):130-40. PubMed ID: 16226334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical characteristics and aerosolization performance of insulin dry powders for inhalation prepared by a spray drying method.
    You Y; Zhao M; Liu G; Tang X
    J Pharm Pharmacol; 2007 Jul; 59(7):927-34. PubMed ID: 17637186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based spray-dried respirable powders for sustained delivery of terbutaline sulfate.
    Learoyd TP; Burrows JL; French E; Seville PC
    Eur J Pharm Biopharm; 2008 Feb; 68(2):224-34. PubMed ID: 17560772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of absorption enhancers to enhance the dispersibility of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Aug; 7(8):1035-43. PubMed ID: 15756712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
    Marriott C; MacRitchie HB; Zeng XM; Martin GP
    Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Box-Behnken optimization design and enhanced oral bioavailability of thymopentin-loaded poly (butyl cyanoacrylate) nanoparticles.
    Jin X; Huang A; Ping Q; Cao F; Su Z
    Pharmazie; 2011 May; 66(5):339-47. PubMed ID: 21699067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy.
    Li HY; Seville PC; Williamson IJ; Birchall JC
    J Gene Med; 2005 Mar; 7(3):343-53. PubMed ID: 15515142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of potential inhalation carriers on stability of thymopentin in rat bronchoalveolar lavage fluid.
    Cai C; Wang L; Dong W; Tang X
    Drug Deliv; 2014 Sep; 21(6):495-500. PubMed ID: 24611940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols.
    Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM
    Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the interactions of amino acid components on a mannitol-based spray-dried powder formulation for pulmonary delivery: A design of experiment approach.
    Sou T; Orlando L; McIntosh MP; Kaminskas LM; Morton DA
    Int J Pharm; 2011 Dec; 421(2):220-9. PubMed ID: 21963471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation and pharmaceutical properties of salcatonin dry powder inhalations].
    Xiong LJ; Zhu JB
    Yao Xue Xue Bao; 2003 Mar; 38(3):218-22. PubMed ID: 12830721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Research on thymopentin-loaded N-trimethyl chitosan nanoparticles administered through mouth].
    Tang SW; Yuan XJ; Zhang ZR; Song QG; He Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Sep; 38(5):885-8. PubMed ID: 17953385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of lectin-conjugated PLGA nanoparticles for oral delivery of thymopentin.
    Yin Y; Chen D; Qiao M; Lu Z; Hu H
    J Control Release; 2006 Dec; 116(3):337-45. PubMed ID: 17097180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and testing of particulate formulations for the nasal delivery of antibodies.
    Kaye RS; Purewal TS; Alpar OH
    J Control Release; 2009 Apr; 135(2):127-35. PubMed ID: 19059291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats.
    Bosquillon C; Préat V; Vanbever R
    J Control Release; 2004 Apr; 96(2):233-44. PubMed ID: 15081215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-spray-dried mannitol-ciprofloxacin dry powder inhaler formulation for cystic fibrosis and chronic obstructive pulmonary disease.
    Adi H; Young PM; Chan HK; Agus H; Traini D
    Eur J Pharm Sci; 2010 Jun; 40(3):239-47. PubMed ID: 20371286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivesicular liposomes for the sustained release of thymopentin: stability, pharmacokinetics and pharmacodynamics.
    Zuo J; Gong T; Sun X; Huang Y; Peng Q; Zhang Z
    Pharmazie; 2012 Jun; 67(6):507-12. PubMed ID: 22822538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
    Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
    Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.